Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/00 → 1/1/00 |
Funding
- Pfizer, Inc.: $12,980.26
Protocol No. C5261001: A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza in Healthy Individuals
- Rupp, Richard (PI)
Project: Other project